Houbao Liu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 7
-
- Peptidase Inhibition and Analysis 5
- Pancreatic and Hepatic Oncology Research 4
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 24
-
- RNA modifications and cancer 6
- Glycosylation and Glycoproteins Research 3
-
- Gallbladder and Bile Duct Disorders 6
-
- Microtubule and mitosis dynamics 3
- Cited by
- Cancer ResearchOncologySurgery
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (2 papers)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited KingdomPakistan
In The Last Decade
Houbao Liu
43 papers receiving 540 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 173
- Oncology 199
- Surgery 177
- Molecular Biology 274
- Pulmonary and Respiratory Medicine 123
Countries citing papers authored by Houbao Liu
This map shows the geographic impact of Houbao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Houbao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Houbao Liu more than expected).
Fields of papers citing papers by Houbao Liu
This network shows the impact of papers produced by Houbao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Houbao Liu. The network helps show where Houbao Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Houbao Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 12 | |
| 8 | 2022 | 6 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 4 | |
| 11 | 2020 | 11 | |
| 12 | 2020 | 3 | |
| 13 | 2019 | 10 | |
| 14 | 2019 | 25 | |
| 15 | 2018 | 24 | |
| 16 | 2017 | 15 | |
| 17 | 2016 | 30 | |
| 18 | 2015 | 12 | |
| 19 | 2015 | 27 | |
| 20 | 2014 | 16 |
About Houbao Liu
Houbao Liu is a scholar working on Cancer Research, Oncology and Surgery, having authored 45 papers that have together received 544 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers), Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers), Gallbladder and Bile Duct Disorders (6 papers), Peptidase Inhibition and Analysis (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Microtubule and mitosis dynamics (3 papers). The work is most often cited by research in Cancer Research (173 citations), Oncology (199 citations) and Surgery (177 citations). Houbao Liu has collaborated with scholars based in China, United Kingdom and Pakistan. Frequent co-authors include Tao Suo, Yueqi Wang, Sheng Shen, Dexiang Zhang, Xiaobo Bo, Han Liu, Jiwen Wang, Xiaoling Ni, Changcheng Wang and Jie Wang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.